Protein microarrays for cancer diagnostics and therapy

Medical Principles and Practice

Volumn 19, Issue 4, 2010, Pages 247-254

  Lin, Jimmy Cheng Ho ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cancer; Mass spectrometry; Protein array; Proteomics

Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INTERLEUKIN 8;

BREAST CANCER; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER RESISTANCE; CANCER THERAPY; HUMAN; LUNG CANCER; PANCREAS CANCER; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

HUMANS; MASS SPECTROMETRY; NEOPLASMS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953210729     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000312709     Document Type: Review

References (59)

1. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al: The sequence of the human genome. Science 2001; 291: 1304-1351.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al: Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
3. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al: The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314: 268-274.
4. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al: The genomic landscapes of human breast and colorectal cancers. Science 2007; 318: 1108-1113.
5. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al: An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-1812.
6. TCGA: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-1068.
7. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et al: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321: 1801-1806.
8. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, et al: Characterizing the cancer genome in lung adenocarcinoma. Nature 2007; 450: 893-898.
9. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, et al: Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069-1075.
10. Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med 2004; 10: 789-799.
11. Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF 3rd: Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003; 3: 317-325.
12. Jaras K, Ressine A, Nilsson E, Malm J, Marko-Varga G, Lilja H, Laurell T: Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective. Anal Chem 2007; 79: 5817-5825.
13. Lueking A, Cahill DJ, Mullner S: Protein biochips: a new and versatile platform technology for molecular medicine. Drug Discov Today 2005; 10: 789-794.
14. Shingyoji M, Gerion D, Pinkel D, Gray JW, Chen F: Quantum dots-based reverse phase protein microarray. Talanta 2005; 67: 472-478.
15. Haab BB, Dunham MJ, Brown PO: Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001; 2:RESEARCH0004.
16. Bock C, Coleman M, Collins B, Davis J, Foulds G, Gold L, Greef C, Heil J, Heilig JS, Hicke B, et al: Photoaptamer arrays applied to multiplexed proteomic analysis. Proteomics 2004; 4: 609-618.
17. Petach H, Gold L: Dimensionality is the issue: use of photoaptamers in protein microarrays. Curr Opin Biotechnol 2002; 13: 309-314.
18. Li Y, Lee HJ, Corn RM: Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging. Anal Chem 2007; 79: 1082-1088.
19. Knight CG, Platt M, Rowe W, Wedge DC, Khan F, Day PJ, McShea A, Knowles J, Kell DB: Array-based evolution of DNA aptamers allows modelling of an explicit sequencefitness landscape. Nucleic Acids Res 2009; 37:e6.
20. MacBeath G, Schreiber SL: Printing proteins as microarrays for high-throughput function determination. Science 2000; 289: 1760-1763.
21. Sevecka M, MacBeath G: State-based discovery: a multidimensional screen for smallmolecule modulators of EGF signaling. Nat Methods 2006; 3: 825-831.
22. Jones RB, Gordus A, Krall JA, MacBeath G: A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 2006; 439: 168-174. (Pubitemid 43083134)
23. Woodbury RL, Varnum SM, Zangar RC: Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA. J Proteome Res 2002; 1: 233-237.
24. Celis JE, Gromov P, Cabezon T, Moreira JM, Ambartsumian N, Sandelin K, Rank F, Gromova I: Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics 2004; 3: 327-344.
25. Celis JE, Moreira JM, Cabezon T, Gromov P, Friis E, Rank F, Gromova I: Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics 2005; 4: 492-522.
26. Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C, Huang RP: Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 2004; 109: 507-515.
27. Hudelist G, Pacher-Zavisin M, Singer CF, Holper T, Kubista E, Schreiber M, Manavi M, Bilban M, Czerwenka K: Use of highthroughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res Treat 2004; 86: 281-291.
28. Hudelist G, Singer CF, Kubista E, Czerwenka K: Use of high-throughput arrays for profiling differentially expressed proteins in normal and malignant tissues. Anticancer Drugs 2005; 16: 683-689.
29. Smith L, Watson MB, O'Kane SL, Drew PJ, Lind MJ, Cawkwell L: The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol Cancer Ther 2006; 5: 2115-2120.
30. Vazquez-Martin A, Colomer R, Menendez JA: Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer. Eur J Cancer 2007; 43: 1117-1124.
31. Carlsson A, Wingren C, Ingvarsson J, Ellmark P, Baldertorp B, Ferno M, Olsson H, Borrebaeck CA: Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Eur J Cancer 2008; 44: 472-480.
32. Orchekowski R, Hamelinck D, Li L, Gliwa E, van Brocklin M, Marrero JA, Vande Woude GF, Feng Z, Brand R, Haab BB: Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res 2005; 65: 11193-11202.
33. Ingvarsson J, Wingren C, Carlsson A, Ellmark P, Wahren B, Engstrom G, Harmenberg U, Krogh M, Peterson C, Borrebaeck CA: Detection of pancreatic cancer using antibody microarray-based serum protein profiling. Proteomics 2008; 8: 2211-2219. (Pubitemid 351898027)
34. Gao WM, Kuick R, Orchekowski RP, Misek DE, Qiu J, Greenberg AK, Rom WN, Brenner DE, Omenn GS, Haab BB, et al: Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 2005; 5: 110.
35. Bartling B, Hofmann HS, Boettger T, Hansen G, Burdach S, Silber RE, Simm A: Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 2005; 49: 145-154.
36. Miller JC, Zhou H, Kwekel J, Cavallo R, Burke J, Butler EB, Teh BS, Haab BB: Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 2003; 3: 56-63.
37. Shafer MW, Mangold L, Partin AW, Haab BB: Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease. Prostate 2007; 67: 255-267.
38. Sanchez-Carbayo M, Socci ND, Lozano JJ, Haab BB, Cordon-Cardo C: Profiling bladder cancer using targeted antibody arrays. Am J Pathol 2006; 168: 93-103.
39. Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, Lawrence TS, Chinnaiyan AM: Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 2001; 61: 7585-7593.
40. Ellmark P, Belov L, Huang P, Lee CS, Solomon MJ, Morgan DK, Christopherson RI: Multiplex detection of surface molecules on colorectal cancers. Proteomics 2006; 6: 1791-1802.
41. Belov L, Huang P, Chrisp JS, Mulligan SP, Christopherson RI: Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells. J Immunol Methods 2005; 305: 10-19.
42. Belov L, Mulligan SP, Barber N, Woolfson A, Scott M, Stoner K, Chrisp JS, Sewell WA, Bradstock KF, Bendall L, et al: Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray. Br J Haematol 2006; 135: 184-197.
43. Ellmark P, Ingvarsson J, Carlsson A, Lundin BS, Wingren C, Borrebaeck CA: Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol Cell Proteomics 2006; 5: 1638-1646.
44. Huang RP, Huang R, Fan Y, Lin Y: Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal Biochem 2001; 294: 55-62.
45. Tannapfel A, Anhalt K, Hausermann P, Sommerer F, Benicke M, Uhlmann D, Witzigmann H, Hauss J, Wittekind C: Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol 2003; 201: 238-249.
46. Zhou H, Bouwman K, Schotanus M, Verweij C, Marrero JA, Dillon D, Costa J, Lizardi P, Haab BB: Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements. Genome Biol 2004; 5:R28.
47. Hung KE, Kho AT, Sarracino D, Richard LG, Krastins B, Forrester S, Haab BB, Kohane IS, Kucherlapati R: Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model. J Proteome Res 2006; 5: 1866-1878.
48. Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, Gutkind JS, Liotta LA, Munson PJ, Petricoin EF 3rd, Krizman DB: Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001; 1: 1271-1278.
49. Ghobrial IM, McCormick DJ, Kaufmann SH, Leontovich AA, Loegering DA, Dai NT, Krajnik KL, Stenson MJ, Melhem MF, Novak AJ, et al: Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 2005; 105: 3722-3730.
50. Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T, Yue L, Bray-Ward P, Ward DC: Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 7677-7682.
51. Rapkiewicz A, Espina V, Zujewski JA, Lebowitz PF, Filie A, Wulfkuhle J, Camphausen K, Petricoin EF 3rd, Liotta LA, Abati A: The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology. Cancer 2007; 111: 173-184.
52. Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, et al: Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 2003; 100: 14229-14234.
53. Mendes KN, Nicorici D, Cogdell D, Tabus I, Yli-Harja O, Guerra R, Hamilton SR, Zhang W: Analysis of signaling pathways in 90 cancer cell lines by protein lysate array. J Proteome Res 2007; 6: 2753-2767.
54. Boyd ZS, Wu QJ, O'Brien C, Spoerke J, Savage H, Fielder PJ, Amler L, Yan Y, Lackner MR: Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reversephase protein microarrays. Mol Cancer Ther 2008; 7: 3695-3706.
55. Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, Petricoin EF 3rd: Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003; 3: 2085-2090.
56. Grubb RL, Calvert VS, Wulkuhle JD, Paweletz CP, Linehan WM, Phillips JL, Chuaqui R, Valasco A, Gillespie J, Emmert-Buck M, et al: Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 2003;3:2142-2146.
57. Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, Liotta LA: Laser capture microdissection: molecular analysis of tissue. Science 1997; 278: 1481-1483.
58. Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, et al: Molecular profiling of clinical tissues specimens: feasibility and applications. J Mol Diagn 2000; 2: 60-66.
59. Qiu J, Madoz-Gurpide J, Misek DE, Kuick R, Brenner DE, Michailidis G, Haab BB, Omenn GS, Hanash S: Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res 2004; 3: 261-267